2017, Number 4
Hypodermoclysis: a therapeutic tool for nursing care and health
Language: Portugués
References: 18
Page: 890-904
PDF size: 247.74 Kb.
ABSTRACT
Introduction: hypodermoclysis is an alternative technology used in fluid administration in the subcutaneous space. This technique is presented as a therapeutic strategy that contributes not only to the administration of drugs and fluids, as in aid to stimulate the autonomy and individual self-care.Objective: To identify how hypodermoclysis has been addressed in the literature.
Methods: This is an integrative review, which was conducted a survey of articles published in the databases of MEDLINE; BDENF; CUMED and LILACS, between the years 2005-2015. It is used to search the following descriptors: hypodermoclysis; nursing; cheers.
Conclusions: We selected 11 articles that gave rise to three thematic categories: 1) Subcutaneous therapy, an alternative route for health care; 2) Hypodermoclysis: technique, use and applicability; 3) Hypodermoclysis: technologies in health and nursing staff. Despite the need for further studies on the subject, the hypodermoclysis technique is a therapeutic alternative to nursing care assistance and health. With proven clinical efficacy and the possibility of its use both in the hospital environment, such as at home, they emphasize issues related to comfort, tolerance and patient convenience.
REFERENCES
Klein CG, Cicinnati V, Schmidt H, Ganten T, Scherer MN, Braun F, et al. Compliance and tolerability of subcutaneous hepatitis B immunoglobulin self-administration in liver transplant patients: A prospective, observational, multicenter study. Ann Transplant. 2013 [acesso 7 Jun 2015];18:677-84. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/24335787
Tew WP, Gordon M, Murren J, Dupont J, Pezzulli S, Aghajanian C, et al. Phase 1 Study of VEGF Trap (Aflibercept) Administered Subcutaneously to Patients with Advanced Solid Tumors. Clin Cancer Res. 2010 [acesso em 10 Jun 2015];16(1):358-66. Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211604/
Kurrasch R, Brown JC, Chu M, Craigen J, Overend P, Patel B, et al. Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics. J Rheumatol. 2013 [acesso 2 Jul 2015];40:1089-96. Disponível em: http://www.jrheum.org/content/40/7/1089.full
Spandorfer PR, Mace SE, Okada PJ, Simon HK, Allen CH, Spiro DM, et al. A Randomized Clinical Trial of Recombinant Human Hyaluronidase - Facilitated Subcutaneous Versus Intravenous Rehydration in Mild to Moderately Dehydrated Children in the Emergency Department. Clin Ther. 2012 [acesso 5 Jun 2015];34:2232-45. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/23062548
Bittner B et al. Development of a Subcutaneous Formulation for Trastuzumab- Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen. Arzneimittelforschung. 2012[acesso 2 Jul 2015];62:401-9. Disponível em: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1321831
Azevedo EF. Administração de antibióticos por via subcutânea: uma revisão integrativa da literatura. 2011. 153f [dissertação]. Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto; 2011 [acesso 25 Ago 2015]. Disponível em: http://www.teses.usp.br/teses/disponiveis/22/22132/tde-19012012-104714/pt-br.php